IFNG and type 1 diabetes mellitus: have reported that soluble CD137 induces CD4+ T cell anergy, in turn suppressing antigen-specific T cell proliferation and IL-2/IFN-γ production, thereby delaying progression to end-stage T1D in NOD mice (127).